Home > LAWREVIEW > Vol. 50 > Iss. 2 (2017)
Recommended Citation
Francisco Javier Espinosa, Big Pharma Versus Inter Partes Review: Why the Pharmaceutical Industry Should Seek Logical Hatch-Waxman Reform over Inter Partes Review Exemption, 50 J. Marshall L. Rev. 337 (2017)
COinS